Sankaran Sid 4

What Happened

• Sankaran Sid, a director of Oscar Health, received an award of 1,203 deferred stock units on April 9, 2026. The units were reported at $14.54 each, for a reported value of $17,492. This was an award (compensation) issued in lieu of a cash retainer, not an open-market purchase or sale.

Key Details

• Transaction date and price: April 9, 2026; 1,203 deferred stock units valued at $14.54 per unit (closing price used).
• Total reported value: $17,492.
• Shares owned after transaction: Not disclosed in the provided filing.
• Footnotes:
  • F1: Each deferred stock unit (DSU) equals the right to receive one share of Class A common stock.
  • F2: DSUs will be settled for cash or shares (issuer's discretion) within 45 days of termination of service, change in control, death, or disability; DSUs issued in lieu of a cash retainer are 100% vested on the grant date.
  • F3: The reporting person elected to receive DSUs under the company’s deferred compensation plan instead of a cash retainer; the April 9 closing stock price was used to calculate the number of units issued.
• Filing date: Form 4 filed April 13, 2026 (reporting the April 9, 2026 grant).

Context

• Deferred stock units are a form of compensation that give the holder a future right to receive shares (or cash) and do not represent an immediate open-market purchase or sale. Because these DSUs were issued in lieu of a cash retainer and are fully vested on grant, this is routine director compensation rather than a direct signal of insider buying or selling.